Relmada Therapeutics, Inc.
RLMD
$0.3618
-$0.0365-9.16%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 44.91M | 54.12M | 70.44M | 83.61M | 96.32M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 886.50K | 1.58M | 537.50K | 752.30K | 1.19M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 45.80M | 55.70M | 70.97M | 84.37M | 97.51M |
|
|
|||||
| Total Current Assets | 45.80M | 55.70M | 70.97M | 84.37M | 97.51M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 22.00K | 22.00K | 53.60K | 43.10K | 43.10K |
| Total Assets | 45.82M | 55.72M | 71.03M | 84.41M | 97.55M |
|
|
|||||
| Total Accounts Payable | 4.13M | 2.35M | 4.17M | 5.19M | 3.51M |
| Total Accrued Expenses | 6.16M | 5.74M | 5.36M | 7.17M | 8.69M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 10.29M | 8.09M | 9.54M | 12.36M | 12.19M |
|
|
|||||
| Total Current Liabilities | 10.29M | 8.09M | 9.54M | 12.36M | 12.19M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 4.50K | 12.60K | -- | -- | -- |
| Total Liabilities | 10.30M | 8.10M | 9.54M | 12.36M | 12.19M |
|
|
|||||
| Common Stock & APIC | 676.40M | 669.85M | 661.99M | 654.78M | 646.26M |
| Retained Earnings | -640.88M | -622.22M | -600.50M | -582.73M | -560.90M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 35.52M | 47.63M | 61.49M | 72.05M | 85.36M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 35.52M | 47.63M | 61.49M | 72.05M | 85.36M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 35.52M | 47.63M | 61.49M | 72.05M | 85.36M |
|
|
|||||